Accordingly, with MM cell lines and patients, in BTZ-resistant samples, low levels of XBP1 and s-XBP1 were detected, along with reduced ATF6 expression, eIF2α-induced protein synthesis inhibition, and overall attenuated immunoglobulin production. The gene discussed is ATF6; the disease is Miyoshi myopathy.